Gut microbiome influences efficacy of PD-1 -based immunotherapy against epithelial tumors, Science, vol.359, pp.91-98, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01727917
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients, Science, vol.359, pp.104-112, 2018. ,
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients, Science, vol.359, pp.97-103, 2018. ,
,
, , 13009.
,